. Author manuscript; available in PMC: 2019 Mar 10.

Published in final edited form as: J Control Release. 2018 Feb 2;273:147–159. doi: 10.1016/j.jconrel.2018.01.027

Table 2.

Summary of immunization groups testing controlled ovalbumin delivery.

Immunization group	OVA dose (μg)	MPL dose (μg)	Alum dose (μg)	MP dose (mg)
Ovalbumin microparticles (20% cyclic acetal coverage) (20% OVA MPs)	10	-	-	1.26
40% OVA MPs		-	-	1.42
60% OVA MPs		-	-	1.00
20% OVA MPs + monophosphoryl lipid A (20% OVA MPs + MPL)		10	-	1.26
40% OVA MPs + MPL			-	1.42
60% OVA MPs + MPL			-	1.00
soluble OVA + MPL (solOVA + MPL)			-	-
solOVA + Alhydrogel (solOVA + alum)		-	250	-
solOVA + empty MPs (solOVA + EMPs)		-	-	1.42
solOVA		-	-	-
PBS	-	-	-	-